ERBB2 and non-small cell lung carcinoma: Therefore, through pan-cancer analysis, it is found that the detection of HER2 can benefit from the precise diagnosis and targeted therapy of head and neck squamous cell carcinoma (HNSC), non-small cell lung cancer (NSCLC), (CESC), BLCA, and UCEC15.